Literature DB >> 22030692

Targeting JunD: a potential strategy to counteract hormone-refractory prostate cancer.

Devanand Sarkar, Xiang-Yang Wang, Paul B Fisher.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22030692      PMCID： PMC3356832          DOI： 10.4161/cc.10.20.17668

Source DB:  PubMed          Journal:  Cell Cycle        ISSN： 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  9 in total

1.  Androgen receptor requires JunD as a coactivator to switch on an oxidative stress generation pathway in prostate cancer cells.

Authors:  Farideh Mehraein-Ghomi; Hirak S Basu; Dawn R Church; F Michael Hoffmann; George Wilding
Journal:  Cancer Res       Date:  2010-05-11       Impact factor: 12.701

2.  JunD-mediated repression of GADD45α and γ regulates escape from cell death in prostate cancer.

Authors:  Luiz Fernando Zerbini; Jaíra Ferreira de Vasconcellos; Akos Czibere; Yihong Wang; Juliano D Paccez; Xuesong Gu; Jin-Rong Zhou; Towia A Libermann
Journal:  Cell Cycle       Date:  2011-08-01       Impact factor: 4.534

3.  Mammalian genes coordinately regulated by growth arrest signals and DNA-damaging agents.

Authors:  A J Fornace; D W Nebert; M C Hollander; J D Luethy; M Papathanasiou; J Fargnoli; N J Holbrook
Journal:  Mol Cell Biol       Date:  1989-10       Impact factor: 4.272

4.  Blockage of NF-kappaB induces serine 15 phosphorylation of mutant p53 by JNK kinase in prostate cancer cells.

Authors:  Luiz F Zerbini; Yihong Wang; Ricardo G Correa; Je-Yoel Cho; Towia A Libermann
Journal:  Cell Cycle       Date:  2005-09-24       Impact factor: 4.534

5.  Mammalian GADD34, an apoptosis- and DNA damage-inducible gene.

Authors:  M C Hollander; Q Zhan; I Bae; A J Fornace
Journal:  J Biol Chem       Date:  1997-05-23       Impact factor: 5.157

6.  A family of stress-inducible GADD45-like proteins mediate activation of the stress-responsive MTK1/MEKK4 MAPKKK.

Authors:  M Takekawa; H Saito
Journal:  Cell       Date:  1998-11-13       Impact factor: 41.582

7.  Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.

Authors:  Luiz F Zerbini; Yihong Wang; Je-Yoel Cho; Towia A Libermann
Journal:  Cancer Res       Date:  2003-05-01       Impact factor: 12.701

Review 8.  Growth arrest and DNA damage-45 alpha (GADD45alpha).

Authors:  A Rosemary Siafakas; Des R Richardson
Journal:  Int J Biochem Cell Biol       Date:  2008-08-05       Impact factor: 5.085

Review 9.  Multiple facets of junD gene expression are atypical among AP-1 family members.

Authors:  J M Hernandez; D H Floyd; K N Weilbaecher; P L Green; K Boris-Lawrie
Journal:  Oncogene       Date:  2008-04-21       Impact factor: 9.867
  9 in total
  3 in total

1.  Tead and AP1 Coordinate Transcription and Motility.

Authors:  Xiangfan Liu; Huapeng Li; Mihir Rajurkar; Qi Li; Jennifer L Cotton; Jianhong Ou; Lihua J Zhu; Hira L Goel; Arthur M Mercurio; Joo-Seop Park; Roger J Davis; Junhao Mao
Journal:  Cell Rep       Date:  2016-01-28       Impact factor: 9.423

2.  Molecular signatures in the prevention of radiation damage by the synergistic effect of N-acetyl cysteine and qingre liyan decoction, a traditional chinese medicine, using a 3-dimensional cell culture model of oral mucositis.

Authors:  Maria P Lambros; Lavanya Kondapalli; Cyrus Parsa; Hari Chandana Mulamalla; Robert Orlando; Doreen Pon; Ying Huang; Moses S S Chow
Journal:  Evid Based Complement Alternat Med       Date:  2015-01-29       Impact factor: 2.629

3.  ellipsoidFN: a tool for identifying a heterogeneous set of cancer biomarkers based on gene expressions.

Authors:  Xianwen Ren; Yong Wang; Luonan Chen; Xiang-Sun Zhang; Qi Jin
Journal:  Nucleic Acids Res       Date:  2012-12-22       Impact factor: 16.971
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.